Massachusetts lost biomanufacturing jobs last year, raising questions about the sector’s future in the state. But local and state leaders are planning initiatives to show the Bay State remains a formidable powerhouse.
Developers delivered the core and shell of a 288,000-square-foot lab and research building following the renovation and conversion of office space in a Bedford business park.
Yes, unbuilt suburban lab projects are unraveling and rents are sinking, but the life science industry is built on real demand and requires in-person work. Life science real estate isn’t going anywhere in Boston.
A 1960s office park near Route 128 would be replaced by a life science project under plans under review by Waltham officials.
National Development is positioning its next projects at The District to attract more life science tenants to Burlington’s growing lab cluster.
After adding a hotel and restaurants to The District office park in Burlington, National Development proposes three life science buildings totaling 665,000 square feet to add momentum to the town’s growing lab market.
The new owners of a Burlington office building received $87 million to convert the property into 175,000 square feet of life science space.
The new owners of a Canton call center plan a speculative redevelopment into a 126,460-square-foot cGMP facility.
A 130-acre site near the Braintree-Weymouth line would become a new biomanufacturing hub under plans by a Hingham developer.
A nearly 300,000-square-foot research lab and biomanufacturing complex would replace a group of industrial tenants in a planned redevelopment of a 15-acre property near the MBTA’s Anderson Regional Transportation Center in Woburn.
Suburban developer Hobbs Brook Real Estate has named a new CEO to replace former chief executive Sam Schafer.
After recently completing a 289-unit apartment complex in Woburn, a Boston developer submitted plans to redevelop a 14-acre nearby industrial site as lab and biomanufacturing space.
A medical device company is leasing 100,000 square feet at 400 Wood Road in Braintree, the redevelopment of the former Haemonetics Corp. headquarters.
Kendall Square-based Broad Institute is expanding to a new suburban campus within Burlington’s Network Drive that will house genetic sequencing research space.
In its latest acquisition spree, life science developer King Street Properties paid $68 million for a portfolio of commercial properties near Route 128 in Waltham.
The new owners of a Westwood office building are set to begin a lab conversion that would become available to life science tenants in 2023.
Life science development heavyweight Alexandria Real Estate Equities has paid $341 million for eight properties in Andover’s Minuteman Park, including 1.3 million square feet of existing buildings and potential for a new biomanufacturing complex.
Brookline officials want to position the town’s commercial districts for life science development by removing long standing barriers to lab space. But with square footage under construction starting to outpace requirements, the move could be coming too late.
Partial demolition and renovation of a Lexington office park would create a 686,107-square-foot campus for the growing suburban life science market.
Developers have broken ground on a 227,000-square-foot speculative lab project in Waltham after receiving $277 million in financing from Dallas-based RBC Real Estate Capital Corp.
